Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 52

Results For "central"

757 News Found

Bulk Drug Park in the country :PIB
Policy | July 27, 2022

Bulk Drug Park in the country :PIB

The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park


Pharma manufacturer 'Gansons' turns 75
News | July 18, 2022

Pharma manufacturer 'Gansons' turns 75

Gansons is based in Thane (Maharashtra, India) with global representation in UK, USA, UAE, Central Asia, South Asia and South-East Asia.


Glaucoma Research Foundation launches catalyst for a to prevent and cure neurodegeneration
News | July 18, 2022

Glaucoma Research Foundation launches catalyst for a to prevent and cure neurodegeneration

Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's


Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’
News | July 18, 2022

Strand Life Sciences presents report on ‘Genomic Surveillance of SARS-CoV-2’

Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru


CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine
News | July 15, 2022

CEPI funds consortium led by CPI to advance Caltech’s new all-in-one coronavirus vaccine

Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.


Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'
Policy | July 11, 2022

Govt introduces 'Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022'

The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics


ALPLA acquires Polish packaging manufacturer APON
News | July 08, 2022

ALPLA acquires Polish packaging manufacturer APON

The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019


Lupin’s Somerset manufacturing plant Receives EIR from US FDA
Drug Approval | July 08, 2022

Lupin’s Somerset manufacturing plant Receives EIR from US FDA

The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated


Vacuubrand unveils new corporate identity
News | July 06, 2022

Vacuubrand unveils new corporate identity

VACUUBRAND has evolved rapidly in recent years, developing new innovative vacuum technology for laboratories, research and engineering